Personalis Accelerates Global Expansion with UKCA Marking for NeXT Personal®, Expanding MRD Access and Biopharma Support in Great Britain

(Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced that it has achieved UKCA (United Kingdom Conformity Assessed) marking for its NeXT Personal Dx test. This ...
BMJ Case Reports

Single-stage surgical management of concurrent pulmonary and hepatic hydatidosis

An adolescent boy presented with vague respiratory symptoms and mild right upper quadrant abdominal pain. Following physical ...
The Lancet

Reproductive health guidance for the cystic fibrosis community: a Cystic Fibrosis Foundation Position Paper

The Cystic Fibrosis Foundation organised a multidisciplinary committee to develop this Position Paper to outline current ...